NEW YORK (GenomeWeb) – Abbott announced today that the US Food and Drug Administration has expanded the Emergency Use Authorization for the company's RealTime Zika assay to now include use on whole blood samples.

The agency originally granted the assay EUA in November for use on human serum, EDTA plasma, and urine samples. Now, Abbott will also be able to use the test for detection of the Zika virus in whole blood, when collected alongside patient-matched serum or plasma samples.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jan
30
Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

Feb
21
Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.